Associated Papers
Associations of PNPLA3 and LEP genetic polymorphisms with metabolic-associated fatty liver disease in Thai people living with human immunodeficiency virus.
Choochuay K et al.
World Journal of Hepatology, 2024
A PRISMA-compliant meta-analysis of apolipoprotein C3 polymorphisms and nonalcoholic fatty liver disease.
Chen BF et al.
Journal of the Chinese Medical Association : Jcma, 2021
Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk.
Dabravolski SA et al.
International Journal of Molecular Sciences, 2021
Association between APOC3 polymorphisms and non-alcoholic fatty liver disease risk: a meta-analysis.
Wang J et al.
African Health Sciences, 2020
APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases.
Zhang RN et al.
Digestive Diseases and Sciences, 2016
Apolipoprotein C3 Gene Variants and Risk of Developing Type 2 Diabetes in Saudi Subjects.
Alharbi KK et al.
Metabolic Syndrome and Related Disorders, 2015
Effect of apolipoprotein C3 genetic polymorphisms on serum lipid levels and the risk of intracerebral hemorrhage.
Jiang Y et al.
Lipids in Health and Disease, 2015
Apolipoprotein C3 genetic polymorphisms are associated with lipids and coronary artery disease in a Chinese population.
Cui F et al.
Lipids in Health and Disease, 2014
Apolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population.
Li MR et al.
World Journal of Gastroenterology, 2014
Apolipoprotein c3 gene polymorphisms are not a risk factor for developing non-alcoholic Fatty liver disease: a meta-analysis.
Zhang H et al.
Hepatitis Monthly, 2014
Association between apolipoprotein C3 Sst I, T-455C, C-482T and C1100T polymorphisms and risk of coronary heart disease.
Lin B et al.
Bmj Open, 2014
Polymorphisms in Fas gene is associated with HIV-related lipoatrophy in Thai patients.
Likanonsakul S et al.
Aids Research and Human Retroviruses, 2013
Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content.
Peter A et al.
International Journal of Obesity (2005), 2012
Lack of association between apolipoprotein C3 gene polymorphisms and risk of coronary heart disease in a Han population in East China.
Yu J et al.
Lipids in Health and Disease, 2011
Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans.
Sentinelli F et al.
Lipids in Health and Disease, 2011
Association between the -455T>C promoter polymorphism of the APOC3 gene and the metabolic syndrome in a multi-ethnic sample.
Pollex RL et al.
Bmc Medical Genetics, 2007
Influence of the APOC3 -2854T>G polymorphism on plasma lipid levels: effect of age and gender.
Minihane AM et al.
Biochimica Et Biophysica Acta, 2002